What is the Return on Assets (ROA) of Recursion Pharmaceuticals this year?
The Return on Assets (ROA) of Recursion Pharmaceuticals is -0.5 undefined this year.
Recursion Pharmaceuticals ROA 2024
Recursion Pharmaceuticals ROA
-0.5
Ticker
RXRX
ISIN
US75629V1044
In 2024, Recursion Pharmaceuticals's return on assets (ROA) was -0.5, a 46.97% increase from the -0.34 ROA in the previous year.
Recursion Pharmaceuticals Aktienanalyse
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Recursion Pharmaceuticals's Return on Assets (ROA)
Recursion Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Recursion Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Recursion Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Recursion Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Recursion Pharmaceuticals Stock
What was the ROA of Recursion Pharmaceuticals compared to the previous year?
The ROA of Recursion Pharmaceuticals has increased by 46.97% compared to the previous year.
What consequences do high ROA have for investors of Recursion Pharmaceuticals?
A high ROA is advantageous for investors of Recursion Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Recursion Pharmaceuticals?
A low ROA can be unfavorable for investors of Recursion Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Recursion Pharmaceuticals affect the company?
An increase in ROA of Recursion Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Recursion Pharmaceuticals impact the company?
A reduction in the ROA of Recursion Pharmaceuticals can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Recursion Pharmaceuticals?
Some factors that can influence the ROA of Recursion Pharmaceuticals include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Recursion Pharmaceuticals important for investors?
The ROA of Recursion Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Recursion Pharmaceuticals take to improve ROA?
To improve ROA, Recursion Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Recursion Pharmaceuticals pay?
Over the past 12 months, Recursion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Recursion Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Recursion Pharmaceuticals?
The current dividend yield of Recursion Pharmaceuticals is .
When does Recursion Pharmaceuticals pay dividends?
Recursion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Recursion Pharmaceuticals?
Recursion Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Recursion Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Recursion Pharmaceuticals located?
Recursion Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Recursion Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Recursion Pharmaceuticals from 6/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.
When did Recursion Pharmaceuticals pay the last dividend?
The last dividend was paid out on 6/17/2024.
What was the dividend of Recursion Pharmaceuticals in the year 2023?
In the year 2023, Recursion Pharmaceuticals distributed 0 USD as dividends.
In which currency does Recursion Pharmaceuticals pay out the dividend?
The dividends of Recursion Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Recursion Pharmaceuticals
Our stock analysis for Recursion Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recursion Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Recursion Pharmaceuticals Revenue
- Recursion Pharmaceuticals Net Income
- Recursion Pharmaceuticals P/E
- Recursion Pharmaceuticals P/S
- Recursion Pharmaceuticals EBIT
- Recursion Pharmaceuticals Dividend
- Recursion Pharmaceuticals Stocks
- Recursion Pharmaceuticals Market capitalization
- Recursion Pharmaceuticals Debt
- Recursion Pharmaceuticals Liabilities
- Recursion Pharmaceuticals Equity
- Recursion Pharmaceuticals AAQS
- Recursion Pharmaceuticals Employees
- Recursion Pharmaceuticals ROE
- Recursion Pharmaceuticals ROA
- Recursion Pharmaceuticals ROCE